MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.

Volume 6 (2009), Issue 6 (June)

1. Antibiotic prophylaxis for the prevention of infection after major limb amputation.
   Eur J Vasc Endovasc Surg, 37(6): 696-703. [Abstract] [Full-text]
2. Methicillin-resistant Staphylococcus aureus in Spain: molecular epidemiology and utility of different typing methods.
   J Clin Microbiol, 47(6): 1620-7. [Abstract] [Full-text]
3. Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005.
   J Clin Microbiol, 47(6): 1628-30. [Abstract] [Full-text]
4. Cost-effective frozen master mix modification of a commercial methicillin-resistant Staphylococcus aureus PCR assay.
   J Clin Microbiol, 47(6): 1888-91. [Abstract] [Full-text]
5. Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years.
   J Clin Microbiol, 47(6): 1640-4. [Abstract] [Full-text]
6. Evaluation of the BD GeneOhm StaphSR assay for detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from spiked positive blood culture bottles.
   J Clin Microbiol, 47(6): 1689-94. [Abstract] [Full-text]
7. Community-Associated Methicillin-Resistant Staphylococcus aureus Skin and Soft-Tissue Infection in HIV-Infected Patients.
   J Int Assoc Physicians AIDS Care (Chic Ill), 8(3): 176-80. [Abstract] [Full-text]
8. Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe.
   Crit Care, 13(3): R80. [Abstract] [Full-text]
9. Incidence of acquisition of methicillin-resistant Staphylococcus aureus, Clostridium difficile, and other health-care-associated pathogens by dogs that participate in animal-assisted interventions.
   J Am Vet Med Assoc, 234(11): 1404-17. [Abstract] [Full-text]
10. Antibiotic susceptibility of conjunctival bacterial isolates from refractive surgery patients.
    Ophthalmology, 116(6): 1067-74. [Abstract] [Full-text]
11. How does healthcare worker hand hygiene behaviour impact upon the transmission of MRSA between patients?: an analysis using a Monte Carlo model.
    BMC Infect Dis, 9: 64. [Abstract] [Full-text]
12. Effect of risk-stratified, protocol-based perioperative chemoprophylaxis on nosocomial infection rates in a series of 31 927 consecutive neurosurgical procedures (1994-2006).
    Neurosurgery, 64(6): 1123-30; discussion 1130-1. [Abstract] [Full-text]
13. Characterization of ermA in Macrolide-Susceptible Strains of Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
14. AFN-1252, a FabI Inhibitor, Demonstrates a Staphylococcal-Specific Spectrum of Activity.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
15. Holocord spinal epidural abscess.
    J Child Neurol, 24(6): 768-71. [Abstract] [Full-text]
16. Ceftobiprole: a new beta-lactam antibiotic.
    Int J Clin Pract, 63(6): 930-43. [Abstract] [Full-text]
17. Silver doped perfluoropolyether-urethane coatings: antibacterial activity and surface analysis.
    Colloids Surf B Biointerfaces, 72(1): 62-7. [Abstract] [Full-text]
18. The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals.
    Eur J Health Econ, 10(3): 287-97. [Abstract] [Full-text]
19. Comparison of Austrian, Hungarian and Macedonian methicillin-resistant and methicillin-sensitive Staphylococcus aureus strains in relation to prevalence of cytotoxin genes.
    Microb Pathog, 46(6): 328-36. [Abstract] [Full-text]
20. Periprosthetic infection due to resistant staphylococci: serious problems on the horizon.
    Clin Orthop Relat Res, 467(7): 1732-9. [Abstract] [Full-text]
21. Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections associated with surgical procedures.
    Am J Surg, 197(6): 791-6. [Abstract] [Full-text]
22. Effect of linezolid compared with glycopeptides in methicillin-resistant Staphylococcus aureus severe pneumonia in piglets.
    Chest, 135(6): 1564-71. [Abstract] [Full-text]
23. Phenotypic and genotypic evaluation of aminoglycoside resistance in clinical isolates of staphylococci in Tehran, Iran.
    Microb Drug Resist, 15(2): 129-32. [Abstract] [Full-text]
24. Elevated creatine phosphokinase levels associated with linezolid therapy.
    Am J Health Syst Pharm, 66(12): 1097-100. [Abstract] [Full-text]
25. Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007).
    Diagn Microbiol Infect Dis, 64(2): 177-84. [Abstract] [Full-text]
26. Heterogeneity of methicillin-resistant Staphylococcus aureus strains (MRSA) characterized by flow cytometry.
    Curr Microbiol, 59(1): 78-80. [Abstract] [Full-text]
27. Loss of vancomycin bactericidal activity against accessory gene regulator (agr) dysfunctional Staphylococcus aureus under conditions of high bacterial density.
    Diagn Microbiol Infect Dis, 64(2): 220-4. [Abstract] [Full-text]
28. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus associated with spread of the ST45 lineage in Hong Kong (DMID-08-518 revised).
    Diagn Microbiol Infect Dis, 64(2): 131-7. [Abstract] [Full-text]
29. Rapid and sensitive detection of methicillin-resistant Staphylococcus periprosthetic infections using real-time polymerase chain reaction.
    Diagn Microbiol Infect Dis, 64(2): 172-6. [Abstract] [Full-text]
30. Induction of Staphylococcus aureus-specific IgA and agglutination potency in milk of cows by mucosal immunization.
    Vaccine, 27(30): 4001-9. [Abstract] [Full-text]
31. Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States.
    Clin Infect Dis, 49(1): 65-71. [Abstract] [Full-text]
32. Quality pneumonia care: distinguishing community-acquired from health care-associated pneumonia.
    Am J Health Syst Pharm, 66(12): S8-14. [Abstract] [Full-text]
33. ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countries.
    Diagn Microbiol Infect Dis, 64(2): 191-201. [Abstract] [Full-text]
34. Septic arthritis and acute hematogenous osteomyelitis in childhood at a tertiary hospital in Japan.
    Pediatr Int, 51(3): 371-6. [Abstract] [Full-text]
35. Methicillin-resistant Staphylococcus aureus colonization, behavioral risk factors, and skin and soft-tissue infection at an ambulatory clinic serving a large population of HIV-infected men who have sex with men.
    Clin Infect Dis, 49(1): 118-21. [Abstract] [Full-text]
36. Comparison of community-associated methicillin-resistant Staphylococcus aureus from teaching hospitals in London and the USA, 2004-2006: where is USA300 in the UK?
    Eur J Clin Microbiol Infect Dis, 28(7): 835-9. [Abstract] [Full-text]
37. Molecular epidemiological analysis of methicillin-resistant Staphylococcus aureus isolates from Chinese pediatric patients.
    Eur J Clin Microbiol Infect Dis, 28(7): 861-4. [Abstract] [Full-text]
38. Daptomycin resistance and treatment failure following vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE).
    Eur J Clin Microbiol Infect Dis, 28(7): 831-3. [Abstract] [Full-text]
39. Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice.
    J Antimicrob Chemother, 64(1): 94-100. [Abstract] [Full-text]
40. The inability of a bacteriophage to infect Staphylococcus aureus does not prevent it from specifically delivering a photosensitizer to the bacterium enabling its lethal photosensitization.
    J Antimicrob Chemother, 64(1): 59-61. [Abstract] [Full-text]
41. Development of homogeneous expression of resistance in methicillin-resistant Staphylococcus aureus clinical strains is functionally associated with a beta-lactam-mediated SOS response.
    J Antimicrob Chemother, 64(1): 37-45. [Abstract] [Full-text]
42. Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects.
    J Antimicrob Chemother, 64(1): 9-15. [Abstract] [Full-text]
43. Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.
    Bioorg Med Chem Lett, 19(13): 3374-7. [Abstract] [Full-text]
44. The relative roles of bacteria and host inflammatory cells in SIgA degradation.
    J Trauma, 66(6): 1556-62; discussion 1562-3. [Abstract] [Full-text]
45. Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk.
    Infect Control Hosp Epidemiol, 30(7): 623-32. [Abstract] [Full-text]
46. Pediatric and neonatal Staphylococcus aureus bacteremia: epidemiology, risk factors, and outcome.
    Infect Control Hosp Epidemiol, 30(7): 636-44. [Abstract] [Full-text]
47. Monitoring the effectiveness of hospital cleaning practices by use of an adenosine triphosphate bioluminescence assay.
    Infect Control Hosp Epidemiol, 30(7): 678-84. [Abstract] [Full-text]
48. Nosocomial blood stream infection in intensive care units at Assiut University Hospitals (Upper Egypt) with special reference to extended spectrum beta-lactamase producing organisms.
    BMC Res Notes, 2: 76. [Abstract] [Full-text]
49. Novel fit for purpose single use tourniquet: best of both worlds.
    J Med Eng Technol. [Abstract] [Full-text]
50. Endogenous endophthalmitis caused by methicillin-resistant Staphylococcus aureus (MRSA).
    Retina, 29(6): 831-4. [Abstract] [Full-text]
51. Etiology of neonatal blood stream infections in Tbilisi, Republic of Georgia.
    Int J Infect Dis, 13(4): 499-505. [Abstract] [Full-text]
52. Ecthyma-gangrenosum-like lesions associated with methicillin-resistant Staphylococcus aureus infection.
    Int J Infect Dis, 13(4): e173-5. [Abstract] [Full-text]
53. Anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of MC21-B, an antibacterial compound produced by the marine bacterium Pseudoalteromonas phenolica O-BC30T.
    Int J Antimicrob Agents, 34(2): 131-5. [Abstract] [Full-text]
54. Molecular characterisation of meticillin-resistant Staphylococcus aureus isolates from two ceftobiprole Phase 3 complicated skin and skin-structure infection clinical trials.
    Int J Antimicrob Agents, 34(2): 166-8. [Abstract] [Full-text]
55. Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections.
    Int J Antimicrob Agents, 34(2): 148-55. [Abstract] [Full-text]
56. A prospective study of methicillin-resistant Staphylococcus aureus colonization in children scheduled for elective surgery.
    J Pediatr Surg, 44(6): 1197-200; discussion 1200. [Abstract] [Full-text]
57. Serious infections due to methicillin-resistant Staphylococcus aureus: an evolving challenge for physicians.
    Eur J Intern Med, 20(4): 343-7. [Abstract] [Full-text]
58. Methicillin resistant Staphylococcus aureus (MRSA): Diagnostic, clinical relevance and therapy.
    J Dtsch Dermatol Ges, 7(6): 544-51; quiz 552-3. [Abstract] [Full-text]
59. Clinical importance of Stenotrophomonas maltophilia nosocomial pneumonia due to its high mortality in hemodialysis patients.
    Ther Apher Dial, 13(3): 193-8. [Abstract] [Full-text]
60. Ceftobiprole: a new broad spectrum cephalosporin.
    Expert Opin Pharmacother, 10(10): 1675-86. [Abstract] [Full-text]
61. Microbial Spectrum in Surgical Infections Based on a Microbiological Routine Monitoring over the10-Year Period from 1995 to 2004.
    Zentralbl Chir, 134(3): 226-230. [Abstract] [Full-text]
62. Controlling an outbreak of MRSA in the neonatal unit: a steep learning curve.
    Arch Dis Child Fetal Neonatal Ed, 94(4): F307-10. [Abstract] [Full-text]
63. The antimicrobial effect of acetic acid--an alternative to common local antiseptics?
    Burns, 35(5): 695-700. [Abstract] [Full-text]
64. Comparison of acceptability, skin tolerance, and compliance between handwashing and alcohol-based handrub in ICUs: results of a multicentric study.
    Intensive Care Med, 35(7): 1216-24. [Abstract] [Full-text]
65. The arginine catabolic mobile element is not associated with enhanced virulence in experimental invasive disease caused by the community-associated methicillin-resistant Staphylococcus aureus USA300 genetic background.
    Infect Immun, 77(7): 2650-6. [Abstract] [Full-text]
66. HIPP lead to self-health: healthy infection prevention practices in intensive care units.
    Crit Care Nurs Q, 32(3): 242-50; quiz 251-2. [Abstract] [Full-text]
67. Antibacterial Properties of an Iron-based Hemostatic Agent In Vitro and in a Rat Wound Model.
    Acad Emerg Med. [Abstract] [Full-text]
68. Hyperbaric oxygen as adjunctive therapy in experimental mediastinitis.
    J Surg Res, 155(1): 111-5. [Abstract] [Full-text]
69. Doripenem.
    Clin Infect Dis, 49(2): 291-8. [Abstract] [Full-text]
70. Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim.
    Proteins, 76(3): 706-17. [Abstract] [Full-text]
71. The enduring menace of MRSA: incidence, treatment, and prevention in a county jail.
    J Correct Health Care, 15(3): 174-8. [Abstract] [Full-text]
72. A pentaplex PCR assay for the rapid detection of methicillin-resistant Staphylococcus aureus and Panton-Valentine Leucocidin.
    BMC Microbiol, 9: 113. [Abstract] [Full-text]
73. Clustering and risk factors of methicillin-resistant Staphylococcus aureus carriage in two Italian long-term care facilities.
    Infection, 37(3): 216-21. [Abstract] [Full-text]
74. Advances in antibacterial therapy against emerging bacterial pathogens.
    Semin Hematol, 46(3): 198-211. [Abstract] [Full-text]
75. Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies.
    Expert Opin Investig Drugs, 18(7): 921-44. [Abstract] [Full-text]
76. Measuring the effect of enhanced cleaning in a UK hospital: a prospective cross-over study.
    BMC Med, 7: 28. [Abstract] [Full-text]
77. Acute bacterial parotitis following acute stroke.
    Infection, 37(3): 283-5. [Abstract] [Full-text]
78. Comparison of tigecycline and vancomycin for treatment of experimental foreign-body infection due to methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother, 53(7): 3150-2. [Abstract] [Full-text]
79. Soft-tissue penetration of ceftobiprole in healthy volunteers determined by in vivo microdialysis.
    Antimicrob Agents Chemother, 53(7): 2773-6. [Abstract] [Full-text]
80. Efficacy of daptomycin in implant-associated infection due to methicillin-resistant Staphylococcus aureus: importance of combination with rifampin.
    Antimicrob Agents Chemother, 53(7): 2719-24. [Abstract] [Full-text]
81. Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother, 53(7): 3162-5. [Abstract] [Full-text]
82. Novel anion liposome-encapsulated antisense oligonucleotide restores susceptibility of methicillin-resistant Staphylococcus aureus and rescues mice from lethal sepsis by targeting mecA.
    Antimicrob Agents Chemother, 53(7): 2871-8. [Abstract] [Full-text]
83. Resistance selection studies comparing the activity of razupenem (PTZ601) to vancomycin and linezolid against eight methicillin-resistant and two methicillin-susceptible Staphylococcus aureus strains.
    Antimicrob Agents Chemother, 53(7): 3118-21. [Abstract] [Full-text]
84. Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
    Antimicrob Agents Chemother, 53(7): 2785-90. [Abstract] [Full-text]
85. Multicenter, randomized study of the efficacy and safety of intravenous iclaprim in complicated skin and skin structure infections.
    Antimicrob Agents Chemother, 53(7): 2834-40. [Abstract] [Full-text]
86. Activity of telavancin against Staphylococcus aureus strains with various vancomycin susceptibilities in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
    Antimicrob Agents Chemother, 53(7): 2928-33. [Abstract] [Full-text]
87. Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2007: general view of the pathogens' antibacterial susceptibility.
    J Infect Chemother, 15(3): 156-67. [Abstract] [Full-text]
88. Lack of Heteroresistance Among Staphylococcus aureus Isolates With Vancomycin MICs of 2 {micro}g/ml by Automated Testing.
    J Clin Microbiol. [Abstract] [Full-text]
89. Antibacterial diterpenes from Plectranthus ernstii.
    J Nat Prod, 72(6): 1191-4. [Abstract] [Full-text]
90. Assessment of the in vitro efficacy of the novel antimicrobial peptide CECT7121 against human Gram-positive bacteria from serious infections refractory to treatment.
    Chemotherapy, 55(4): 270-7. [Abstract] [Full-text]
91. Cinnamic aldehyde derived probes for the active site labelling of pathogenesis associated enzymes.
    Chem Commun (Camb). [Abstract] [Full-text]
92. Bite-related and septic syndromes caused by cats and dogs.
    Lancet Infect Dis, 9(7): 439-47. [Abstract] [Full-text]
93. Trends in Incidence of Late-Onset Methicillin-Resistant Staphylococcus aureus Infection in Neonatal Intensive Care Units: Data From the National Nosocomial Infections Surveillance System, 1995-2004.
    Pediatr Infect Dis J, 28(7): 577-581. [Abstract] [Full-text]
94. Infection With Community-Onset Staphylococcus aureus and Influenza Virus in Hospitalized Children.
    Pediatr Infect Dis J, 28(7): 572-576. [Abstract] [Full-text]
95. Inhibitory and resistance-modifying potential of plant-based alkaloids against methicillin-resistant Staphylococcus aureus (MRSA).
    Curr Microbiol, 59(2): 181-6. [Abstract] [Full-text]
96. Bacteremia caused by an enterococcus faecalis isolate with high-level linezolid resistance in a teenager with Crohn's disease.
    Pediatr Infect Dis J, 28(7): 663-4. [Abstract] [Full-text]
97. Bacteriology of spontaneously draining acute otitis media in children before and after the introduction of pneumococcal vaccination.
    Pediatr Infect Dis J, 28(7): 640-2. [Abstract] [Full-text]
98. Nursing homes as reservoirs of MRSA: myth or reality?
    J Am Med Dir Assoc, 10(6): 414-8. [Abstract] [Full-text]
99. Effectiveness of honey on Staphylococcus aureus and Pseudomonas aeruginosa biofilms.
    Otolaryngol Head Neck Surg, 141(1): 114-8. [Abstract] [Full-text]
100. Antibiotics, skin and soft tissue infection and meticillin-resistant Staphylococcus aureus: cause and effect.
     Int J Antimicrob Agents, 34: S8-11. [Abstract] [Full-text]
101. Treatment options for skin and soft tissue infections caused by meticillin-resistant Staphylococcus aureus:oralvs.parenteral; home vs. hospital.
     Int J Antimicrob Agents, 34: S30-5. [Abstract] [Full-text]
102. Skin and soft tissue infection: microbiology and epidemiology.
     Int J Antimicrob Agents, 34: S2-7. [Abstract] [Full-text]
103. Why is community-associated MRSA spreading across the world and how will it change clinical practice?
     Int J Antimicrob Agents, 34: S15-9. [Abstract] [Full-text]

© 2004-2012 MRSA Research Today. All Rights Reserved.